Jacobs Levy Equity Management’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-139,714
Closed -$158K 999
2016
Q3
$158K Sell
139,714
-48,193
-26% -$54.5K ﹤0.01% 933
2016
Q2
$276K Buy
+187,907
New +$276K 0.01% 905